Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease

Mild cognitive impairment (MCI) is often considered an early stage of dementia, with estimated rates of progression to dementia up to 80–90% after approximately 6 years from the initial diagnosis. Diagnosis of cognitive impairment in dementia is typically based on clinical evaluation, neuropsycholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Kevin, Salcidua, Stefanny, Orellana, Paulina, Sauma-Pérez, Tania, León, Tomás, Steinmetz, Lorena Cecilia López, Ibañez, Agustín, Duran-Aniotz, Claudia, de la Cruz, Rolando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576366/
https://www.ncbi.nlm.nih.gov/pubmed/37838690
http://dx.doi.org/10.1186/s13195-023-01304-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576366/
https://www.ncbi.nlm.nih.gov/pubmed/37838690
http://dx.doi.org/10.1186/s13195-023-01304-8

Ejemplares similares